Both in Pharmaceuticals
Dare Bioscience vs Biofrontera
Over the past year DARE returned −66.4% and BFRI returned −12.5%; their daily moves had a correlation of 0.10.
DARE −66.4% BFRI −12.5%Growth of $1, one year, split-adjusted
| Metric | DARE | BFRI |
|---|---|---|
| Price | $0.6800 | $0.8864 |
| Market cap | $13.4M | $13.2M |
| Today | +2.56% | +5.55% |
| 1 month | −16.6% | −18.7% |
| 6 months | −67.6% | −19.4% |
| Year to date | −64.8% | +55.5% |
| 1 year | −66.5% | −13.5% |
| Revenue growth (YoY) | — | +32.9% |
| Gross margin | −70.6% | 79.9% |
| Net margin | −1590.4% | −5.0% |
| P/E (TTM) | — | — |
| Price / sales | 9.8× | 0.3× |
| Net cash | $12.5M | $47.0K |
| Dividend yield | — | — |
| Volatility (60d) | 99.5% | 74.7% |
| Short % of float | 6.2% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).